Provided By GlobeNewswire
Last update: Feb 27, 2025
REDWOOD CITY, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the fourth quarter and full year ended December 31, 2024.
Read more at globenewswire.comNASDAQ:SEER (8/1/2025, 8:02:17 PM)
2.13
+0.01 (+0.47%)
Find more stocks in the Stock Screener